Home/Zoetis/Kristin Peck
KP

Kristin Peck

Chief Executive Officer

Zoetis

Zoetis Pipeline

DrugIndicationPhase
APOQUEL (oclacitinib)Canine atopic dermatitisCommercial
CYTOPOINT (lokivetmab)Canine atopic dermatitisCommercial
Revolution PlusFeline parasiticidesCommercial
DraxxinBovine respiratory diseaseCommercial
Suvaxyn PCVPorcine circovirusCommercial
Vanguard Plus 5Canine core vaccinesCommercial
STRONGHOLD PlusFeline parasiticidesCommercial